# OnCo record bcg-and-intravesical-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/bcg-and-intravesical-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "bcg-and-intravesical-therapy" ;
  schema:name "Intravesical therapy (BCG, chemotherapy, devices, gene and viral therapy)"@en ;
  schema:description "Treating early bladder cancer by putting the drug straight into the bladder through a catheter, so the whole body is spared."@en ;
  schema:url <https://onco.cc/technologies/bcg-and-intravesical-therapy/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://uroweb.org/guidelines/non-muscle-invasive-bladder-cancer>, <https://www.cancer.gov/types/bladder/patient/bladder-treatment-pdq> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/devices/> ;
  onco:drugs <https://onco.cc/drugs/bcg-intravesical/>, <https://onco.cc/drugs/tar-200/>, <https://onco.cc/drugs/cretostimogene/>, <https://onco.cc/drugs/nogapendekin-alfa/>, <https://onco.cc/drugs/nadofaragene-firadenovec/> ;
  onco:terms <https://onco.cc/terms/nmibc-vs-mibc/>, <https://onco.cc/terms/bcg-unresponsive/> .